Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 22. Juli 2018
Erweiterte Suche
Abklärungen / Diagnostik
News / Journalscreening
Kongresse / Tagungen
Services / Tools
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 1660  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 33198  
TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Hum Pathol
Jiang Y, Xie J, Wang B, Mu Y, Liu P.
PMID: 30030118 [PubMed - as supplied by publisher]

Lymphocyte-to-monocyte ratio in esophageal squamous cell carcinoma prognosis.
Clin Chim Acta
Hu G, Liu G, Ma JY, Hu RJ.
PMID: 30028962 [PubMed - as supplied by publisher]

Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma.
J Cancer
Liao X, Liu X, Yang C, Wang X, Yu T, Han C, Huang K, Zhu G, Su H, Qin W, Huang R, Yu L, Deng J, Zeng X, Ye X, Peng T.
PMID: 30026832 [PubMed]

Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.
Cancer Causes Control
Murff HJ, Roumie CL, Greevy RA, Hackstadt AJ, McGowan LED, Hung AM, Grijalva CG, Griffin MR.
PMID: 30022336 [PubMed - as supplied by publisher]

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/- nab-paclitaxel in elderly pancreatic cancer patients (GrantPax).
BMC Cancer
Betge J, Chi-Kern J, Schulte N, Belle S, Gutting T, Burgermeister E, Jesenofsky R, Maenz M, Wedding U, Ebert MP, Haertel N.
PMID: 30021548 [PubMed - in process]

Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer.
Br J Surg
Markar SR, Brodie B, Chin ST, Romano A, Spalding D, Hanna GB.
PMID: 30019405 [PubMed - as supplied by publisher]

Unusual Cancers of Childhood Treatment (PDQ®): Patient Version

PDQ Pediatric Treatment Editorial Board, PDQ Pediatric Treatment Editorial Board.
PMID: 26389276 [PubMed]

Safety and efficacy of Nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer suffering from cholestatic hyperbilirubinaemia-A retrospective analysis.
Eur J Cancer
Pelzer U, Wislocka L, Jühling A, Striefler J, Klein F, Roemmler-Zehrer J, Sinn M, Denecke T, Bahra M, Riess H.
PMID: 30014884 [PubMed - as supplied by publisher]

Benefit from the inclusion of surgery in the treatment of patients with stage III pancreatic cancer: a propensity-adjusted, population-based SEER analysis.
Cancer Manag Res
Wang L, Cheng CS, Chen L, Chen Z.
PMID: 30013397 [PubMed]

A Functional Spatial Analysis Platform for Discovery of Immunological Interactions Predictive of Low-Grade to High-Grade Transition of Pancreatic Intraductal Papillary Mucinous Neoplasms.
Cancer Inform
Barua S, Solis L, Parra ER, Uraoka N, Jiang M, Wang H, Rodriguez-Canales J, Wistuba I, Maitra A, Sen S, Rao A.
PMID: 30013304 [PubMed]

Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer.
J Clin Med
Pombeiro I, Loosen SH, Roy S, Schueller F, Niewenhuisen L, Luedde M, Vucur M, Tacke F, Binnebösel M, Schoening W, Trautwein C, Luedde T, Neumann UP, Roderburg C.
PMID: 30011858 [PubMed]

An ultrasensitive polydopamine bi-functionalized SERS immunoassay for exosome-based diagnosis and classification of pancreatic cancer.
Chem Sci
Li TD, Zhang R, Chen H, Huang ZP, Ye X, Wang H, Deng AM, Kong JL.
PMID: 30009009 [PubMed]

Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer.
Cancer Sci
Jin H, Liu P, Wu Y, Meng X, Wu M, Han J, Tan X.
PMID: 30007115 [PubMed - as supplied by publisher]

Management and supportive treatment of frail patients with metastatic pancreatic cancer.
J Geriatr Oncol
Macarulla T, Carrato A, Díaz R, García A, Laquente B, Sastre J, Álvarez R, Muñoz A, Hidalgo M.
PMID: 30005980 [PubMed - as supplied by publisher]

The Role of Notch Signaling and Leptin-Notch Crosstalk in Pancreatic Cancer.
Medicines (Basel)
Harbuzariu A, Oprea-Ilies GM, Gonzalez-Perez RR.
PMID: 30004402 [PubMed]

ABO blood type and risk of hepatocellular carcinoma: a meta-analysis.
Expert Rev Gastroenterol Hepatol
Liu F, Li C, Zhu J, Ren L, Qi X.
PMID: 30004289 [PubMed - as supplied by publisher]

Extracellular vesicles and anti-Cancer drug resistance.
Biochim Biophys Acta
Namee NM, O'Driscoll L.
PMID: 30003999 [PubMed - as supplied by publisher]

CalliSpheres® drug-eluting beads (DEB) transarterial chemoembolization (TACE) is equally efficient and safe in liver cancer patients with different times of previous conventional TACE treatments: a result from CTILC study.
Clin Transl Oncol
Zhang X, Zhou J, Zhu DD, Huang J, Sun JH, Li TF, Shi CS, Sun ZC, Hou QM, Peng ZY, Yu WQ, Ji JS, Gu WJ, Zhou GH, Xie XX, Guo XH, Cao GH, Yu ZH, Xu HH, Fang J, Ying SH, Hu WH, Ji WB, Han J, Wu X, Zheng JP, Luo J, Chen YT, Hu TY, Li L, Hu HJ, Du HJ, Shao GL.
PMID: 30003530 [PubMed - as supplied by publisher]

Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study.
Surg Endosc
Lim C, Osseis M, Lahat E, Doussot A, Sotirov D, Hemery F, Lantéri-Minet M, Feray C, Salloum C, Azoulay D.
PMID: 30003350 [PubMed - as supplied by publisher]

Immunotherapy for pancreatic cancer: Barriers and breakthroughs.
Ann Gastroenterol Surg
Torphy RJ, Zhu Y, Schulick RD.
PMID: 30003190 [PubMed]

   Artikel 1 - 20 / 33198    Seite 1 von 1660  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer



Das Fachportal für Eisenmangel >>


Sky right 1